Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N, N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact Read More > October 23, 2020
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences Read More > October 17, 2020
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study Read More > October 17, 2020
Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness Read More > October 14, 2020
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence Read More > October 11, 2020
Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review Read More > October 5, 2020
The emerging role of psilocybin and MDMA in the treatment of mental illness Read More > September 30, 2020
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Read More > September 24, 2020
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis Read More > September 23, 2020
